• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

miR-526b、miR-655和COX-2在乳腺癌中过表达驱动的不同氧化应激适应性

Distinct Oxidative Stress Adaptations Driven by the Overexpression of miR-526b, miR-655, and COX-2 in Breast Cancer.

作者信息

Opperman Reid M, Maiti Sujit, Majumder Mousumi

机构信息

Department of Biology, John R. Brodie Science Centre, Brandon University, 270 18th Street, Brandon, MB R7A6A9, Canada.

出版信息

Int J Mol Sci. 2025 Sep 18;26(18):9103. doi: 10.3390/ijms26189103.

DOI:10.3390/ijms26189103
PMID:41009689
Abstract

Oxidative stress has a dual role in breast cancer, promoting growth at moderate levels while causing cell death at higher levels, such as during therapeutic interventions that increase reactive oxygen species production. Oncogenic microRNAs miR-526b and miR-655 promote aggressive cancer traits-such as proliferation, migration, invasion, hypoxia response, cancer stem cell properties, and metastasis-via COX-2/EP4/PI3K pathways. These miRNAs and oxidative stress appear to engage in a self-amplifying loop, where miRNA overexpression increases ROS levels, and moderate oxidative stress, in turn, enhances miRNA expression-although the mechanisms are not yet fully understood. This study investigates how overexpressing miR-526b, miR-655, and COX-2 influences breast cancer cell responses to oxidative stress induced by HO. We examined cell viability, DNA damage, and transcriptomic changes in MCF7, MCF7-miR526b, MCF7-miR655, and MCF7-COX2 cell lines. Overexpression of COX-2 provided the most significant protection against oxidative stress, decreasing apoptosis and promoting cell cycle progression. Cells with miR-526b and miR-655 exhibited distinct yet overlapping stress responses, including decreased expression of DNA damage markers and alterations in p53 signaling. RNA-sequencing and network analyses identified hub genes involved in redox balance, immune, and metabolic pathways, which may have clinical significance (, , , ). Overall, these findings suggest that miR-526b, miR-655, and COX-2 play novel roles in promoting resistance to oxidative stress through transcriptional reprogramming in breast cancer; the identified markers could serve as potential biomarkers or therapeutic targets.

摘要

氧化应激在乳腺癌中具有双重作用,在中等水平时促进肿瘤生长,而在较高水平时导致细胞死亡,例如在增加活性氧产生的治疗干预过程中。致癌性微小RNA miR-526b和miR-655通过COX-2/EP4/PI3K途径促进侵袭性癌症特征,如增殖、迁移、侵袭、缺氧反应、癌症干细胞特性和转移。这些微小RNA与氧化应激似乎形成了一个自我放大的循环,微小RNA的过表达会增加活性氧水平,而适度的氧化应激反过来又会增强微小RNA的表达,尽管其机制尚未完全明确。本研究调查了miR-526b、miR-655和COX-2过表达如何影响乳腺癌细胞对过氧化氢诱导的氧化应激的反应。我们检测了MCF7、MCF7-miR526b、MCF7-miR655和MCF7-COX2细胞系中的细胞活力、DNA损伤和转录组变化。COX-2的过表达对氧化应激提供了最显著的保护作用,减少了细胞凋亡并促进了细胞周期进程。miR-526b和miR-655的细胞表现出独特但又重叠的应激反应,包括DNA损伤标志物表达降低和p53信号通路改变。RNA测序和网络分析确定了参与氧化还原平衡、免疫和代谢途径的枢纽基因,这些基因可能具有临床意义(,,,)。总体而言,这些发现表明,miR-526b、miR-655和COX-2在乳腺癌中通过转录重编程促进对氧化应激的抗性方面发挥了新的作用;所确定的标志物可作为潜在的生物标志物或治疗靶点。

相似文献

1
Distinct Oxidative Stress Adaptations Driven by the Overexpression of miR-526b, miR-655, and COX-2 in Breast Cancer.miR-526b、miR-655和COX-2在乳腺癌中过表达驱动的不同氧化应激适应性
Int J Mol Sci. 2025 Sep 18;26(18):9103. doi: 10.3390/ijms26189103.
2
Investigating the effects of miR-526b and miR-655 on doxorubicin sensitivity in breast cancer.研究miR-526b和miR-655对乳腺癌阿霉素敏感性的影响。
Sci Rep. 2025 Sep 29;15(1):33584. doi: 10.1038/s41598-025-18719-y.
3
miR-526b enhances glucose metabolism in breast cancer cells, an effect reversed by targeting the COX-2/EP4 pathway.微小RNA-526b增强乳腺癌细胞中的葡萄糖代谢,这种作用可通过靶向环氧化酶-2/前列腺素E2受体4途径而逆转。
Mol Biol Rep. 2025 Apr 1;52(1):351. doi: 10.1007/s11033-025-10430-5.
4
COX-2 Elevates Oncogenic miR-526b in Breast Cancer by EP4 Activation.COX-2 通过 EP4 激活上调乳腺癌中的致癌 miR-526b。
Mol Cancer Res. 2015 Jun;13(6):1022-33. doi: 10.1158/1541-7786.MCR-14-0543. Epub 2015 Mar 2.
5
Targeting miR-32-5p suppresses c-MYC-driven proliferation and induces apoptosis in MCF-7 breast cancer cells.靶向miR-32-5p可抑制c-MYC驱动的MCF-7乳腺癌细胞增殖并诱导其凋亡。
Med Oncol. 2025 Jul 25;42(9):377. doi: 10.1007/s12032-025-02935-7.
6
Vesicoureteral Reflux膀胱输尿管反流
7
Overexpression of MEOX2 inhibits breast cancer cell metastasis by targeting oxidative stress-induced RGS5.MEOX2的过表达通过靶向氧化应激诱导的RGS5抑制乳腺癌细胞转移。
In Vitro Cell Dev Biol Anim. 2025 Jul 2. doi: 10.1007/s11626-025-01066-7.
8
miR-135b, upregulated in breast cancer, promotes cell growth and disrupts the cell cycle by regulating LATS2.在乳腺癌中上调的miR-135b通过调节LATS2促进细胞生长并扰乱细胞周期。
Int J Oncol. 2016 May;48(5):1997-2006. doi: 10.3892/ijo.2016.3405. Epub 2016 Feb 22.
9
Flavonoids and nitrogen-containing heterocyclic phytochemicals regulate DNA repair via mir-2909-mediated modulation of MRN-checkpoint genes in breast cancer.
Biochem Biophys Res Commun. 2025 Sep 8;778:152404. doi: 10.1016/j.bbrc.2025.152404. Epub 2025 Jul 23.
10
Interplay of oxidative stress and antioxidant mechanisms in cancer development and progression.氧化应激与抗氧化机制在癌症发生和发展中的相互作用。
Arch Toxicol. 2025 Sep 4. doi: 10.1007/s00204-025-04146-5.

本文引用的文献

1
Reactive oxygen species in cancer: Mechanistic insights and therapeutic innovations.癌症中的活性氧:机制洞察与治疗创新
Cell Stress Chaperones. 2025 Aug 5;30(5):100108. doi: 10.1016/j.cstres.2025.100108.
2
CD44: a key regulator of iron metabolism, redox balance, and therapeutic resistance in cancer stem cells.CD44:癌症干细胞中铁代谢、氧化还原平衡及治疗抗性的关键调节因子。
Stem Cells. 2025 May 27;43(6). doi: 10.1093/stmcls/sxaf024.
3
miR-526b enhances glucose metabolism in breast cancer cells, an effect reversed by targeting the COX-2/EP4 pathway.
微小RNA-526b增强乳腺癌细胞中的葡萄糖代谢,这种作用可通过靶向环氧化酶-2/前列腺素E2受体4途径而逆转。
Mol Biol Rep. 2025 Apr 1;52(1):351. doi: 10.1007/s11033-025-10430-5.
4
Targeting MAO-B with Small-Molecule Inhibitors: A Decade of Advances in Anticancer Research (2012-2024).用小分子抑制剂靶向单胺氧化酶B:抗癌研究十年进展(2012 - 2024年)
Molecules. 2024 Dec 31;30(1):126. doi: 10.3390/molecules30010126.
5
Tumor microenvironment-responsive engineered hybrid nanomedicine for photodynamic-immunotherapy via multi-pronged amplification of reactive oxygen species.用于光动力免疫治疗的肿瘤微环境响应性工程化杂化纳米药物:通过多途径放大活性氧实现
Nat Commun. 2025 Jan 6;16(1):424. doi: 10.1038/s41467-024-55658-0.
6
Investigating the clinical significance of OAS family genes in breast cancer: an in vitro and in silico study.研究OAS家族基因在乳腺癌中的临床意义:一项体外和计算机模拟研究。
Hereditas. 2024 Dec 5;161(1):50. doi: 10.1186/s41065-024-00353-9.
7
Monoamine oxidases: A missing link between mitochondria and inflammation in chronic diseases ?单胺氧化酶:慢性疾病中线粒体与炎症之间缺失的一环?
Redox Biol. 2024 Nov;77:103393. doi: 10.1016/j.redox.2024.103393. Epub 2024 Oct 11.
8
Integrated analysis of public datasets for the discovery and validation of survival-associated genes in solid tumors.整合公共数据集以发现和验证实体瘤中与生存相关的基因
Innovation (Camb). 2024 Apr 9;5(3):100625. doi: 10.1016/j.xinn.2024.100625. eCollection 2024 May 6.
9
Cancer statistics, 2024.2024年癌症统计数据。
CA Cancer J Clin. 2024 Jan-Feb;74(1):12-49. doi: 10.3322/caac.21820. Epub 2024 Jan 17.
10
Mechanisms and applications of radiation-induced oxidative stress in regulating cancer immunotherapy.辐射诱导氧化应激在调控癌症免疫治疗中的机制与应用。
Front Immunol. 2023 Aug 4;14:1247268. doi: 10.3389/fimmu.2023.1247268. eCollection 2023.